tiprankstipranks
Rapport Therapeutics, Inc. (RAPP)
NASDAQ:RAPP
US Market

Rapport Therapeutics, Inc. (RAPP) Stock News & Sentiment

9 Followers
Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
PremiumPress Releases
Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
23d ago
BOSTON and SAN DIEGO, June 12, 2024 (GLOBE NEWSWIRE) — Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders, today announced the closing of its initial public offering of 9,200,000 ...Read more

RAPP News on the Web

News Score - Last 7 Days

Positive
RAPP
Sector Average
Media Buzz
This Week3 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RAPP’s Media Buzz Sentiment?
3 articles about RAPP were published this week. In an average week, 1 articles are published.
    What is RAPP’s weekly average amount of articles?
    In an average week, 1 articles about RAPP are published.
      What is RAPP’s News Sentiment?
      100% of articles about RAPP were positive this week, compared to its sector average of 59%.
        General Stocks that are Trending in the News
        ARB-USDArbitrum
        RAPPRapport Therapeutics, Inc.
        DOT-USDPolkadot
        EGLD-USDMultiversX
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis